why choose us

First received: June 11, 2023

Clinical Trial: Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Ischemic Stroke

Study Type: INTERVENTIONAL


Official Title: Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke: An Open-label, Blinded Endpoint, Randomized Controlled Trial

Brief Summary: An open-label, blinded endpoint, randomized controlled trial that includes patients diagnosed with non-disabling, non-large vessel occlusion, acute minor stroke within 4.5 hours of onset.Eligible participants would be randomly assigned to the thrombolysis group (intravenous alteplase) and the dual antiplatelet group (oral aspirin plus clopidogrel).The primary outcome is the proportion of the excellent functional outcome (modified Rankin scale 0-1) at 90 days.

Read more